Prevention of mother-to-child HIV transmission: Similar access for sub-Sahara African immigrants and for French women?

AIDS

Volumn 22, Issue 12, 2008, Pages 1503-1511

  Jasseron, Carine ^a,b   Mandelbrot, Laurent ^a,c,d   Tubiana, Roland ^a,e   Teglas, Jean Paul ^a,f   Faye, Albert ^g   Dollfus, Catherine ^h   Le Chenadec, Jerome ^a,f   Rouzioux, Christine ^c,i   Blanche, Stephane ^c,i   Warszawski, Josiane ^a,b,f,j  

^a INSERM   (France)

^b BICÊTRE HOSPITAL   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d HÔPITAL LOUIS MOURIER   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f INSTITUT NATIONAL D'ÉTUDES DÉMOGRAPHIQUES   (France)

^g HÔPITAL ROBERT DEBRÉ   (France)

^h SERVICE DE DERMATOLOGIE   (France)

ⁱ HÔPITAL NECKER ENFANTS MALADES   (France)

^j UNIVERSITÉ PARIS SACLAY   (France)

more..

Author keywords

Access to care; Africans; Epidemiology; HIV AIDS; Prevention of mother to child transmission; Public health

Indexed keywords

ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; AFRICA; ARTICLE; BREAST FEEDING; DELIVERY; DISEASE TRANSMISSION; FEMALE; FRANCE; HEALTH CARE ACCESS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMIGRANT; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; MOTHER; NEWBORN; PREGNANCY; PRENATAL CARE; PRIORITY JOURNAL; RISK FACTOR; SCREENING; TERM BIRTH; THERAPY DELAY; THIRD TRIMESTER PREGNANCY; VAGINAL DELIVERY; VIRUS LOAD; CLINICAL TRIAL; DRUG ADMINISTRATION; DRUG UTILIZATION; ETHNOLOGY; HEALTH CARE DELIVERY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MASS SCREENING; MULTICENTER STUDY; NEGRO; PREGNANCY COMPLICATION; PROSPECTIVE STUDY; STATISTICS; UTILIZATION REVIEW; VIROLOGY;

AFRICAN CONTINENTAL ANCESTRY GROUP; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DISEASE TRANSMISSION, VERTICAL; DRUG ADMINISTRATION SCHEDULE; DRUG UTILIZATION; FEMALE; FRANCE; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HIV-1; HUMANS; INFANT, NEWBORN; MASS SCREENING; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; PROSPECTIVE STUDIES; VIRAL LOAD;

EID: 49849101982     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3283065b8c     Document Type: Article

References (40)

1. Hamers F, Devaux I, Alix J, Nardone A. HIV/AIDS in Europe: trends and EU-wide priorities. Eurosurveillance 2006; 11:; E061123.1.
2. Sinka K, Mortimer J, Evans B, Morgan D. Impact of the HIV epidemic in sub-Saharan Africa on the pattern of HIV in the UK. Aids 2003; 17:1683-1690.
3. Institut de Veille Sanitaire. The fight against HIV/AIDS and sexually transmitted infections in France. 10 years of surveillance, 1996-2005. Saint-Maurice: Institut de veille sanitaire; 2007:155.
4. Semaille C, Barin F, Cazein F, Pillonel J, Lot F, Brand D, et al. Monitoring the dynamics of the HIV epidemic using assays for recent infection and serotyping among new HIV diagnoses: experience after 2 years in France. J Infect Dis 2007; 196:377-383.
5. Calvez M, Semaille C, Fierro F, Laporte A. Patients from sub-Saharan countries with late access to HIV care: results from the 'Retard survey', France, Nov. 2003-Aug. 2004. BEH 2006; 31:227-229.
6. Lot F, Larsen C, Valin N, Gouezel P, Blanchon T, Laporte A. Sociomedical access of HIV infected patients from sub-Saharan countries followed in hospitals of the Ile de-France region, 2002. BEH 2004; 5:17-20.
7. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994; 331:1173-1180.
8. Warszawski J, Tubiana R, LeChenadecJ, BlancheS, TeglasJP, Dollfus C, et al. Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort. AIDS 2008; 22:289-299.
9. Cooper ER, Charurat M, Mofenson L, Hanson IC, Pitt J, Diaz C, et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr 2002; 29:484-494.
10. Mandelbrot L, Landreau-Mascaro A, Rekacewicz C, Berrebi A, Benifla JL, Burgard M, et al. Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1. JAMA 2001; 285:2083-2093.
11. European Collaborative Study. Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis 2005; 40:458-465.
12. Ioannidis JP, Abrams EJ, Ammann A, Bulterys M, Goedert JJ, Gray L, et al. Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000copies/ml. J Infect Dis 2001; 183:539-545.
13. Newell ML, Huang S, Fiore S, Thorne C, Mandelbrot L, Sullivan JL, et al. Characteristics and management of HI V-1-infected pregnant women enrolled in a randomised trial: differences between Europe and the USA. BMC Infect Dis 2007; 7:60.
14. Yeni P. Management of HIV-infected patients. Paris: Flammar-ion; 2006.
15. Wood E, MontanerJ, Chan K, Tyndall M, Schechter M, Bangs-berg D, et al. Socioeconomic status, access to triple therapy, and survival from HIV-disease since 1996. AIDS Care 2002; 16:2065-2072.
16. Dray-Spira R, Lert F. Living and working with HIV in France in 2003: results from the ANRS-EN12-VESPA Study. Aids 2007; 21 (Suppl 1):S29-S36.
17. Lert F, Obadia Y, VESPA E. How are living HIV-infected persons in France? Population et sociétés 2004; 406.
18. Chee CC, Mortier E, Dupont C, Bloch M, Simonpoli AM, Rouveix E. Medical and social differences between French and migrant patients consulting for the first time for HIV infection. AIDS Care 2005; 17:516-520.
19. Sas Institute. SAS user's guide: basics. 9th ed. Cary, NC: SAS Institute Inc. 2006.
20. Cunningham CK, Balasubramanian R, Delke I, Maupin R, Mofenson L, Dorenbaum A, et al. The impact of race/ethnicity on mother-to-child HIV transmission in the United States in Pediatric AIDS Clinical Trials Group Protocol 316. J Acquir Immune Defic Syndr 2004; 362 :800-807.
21. Manfredi R, Calza L, Chiodo F. HIV disease among immigrants coming to Italy from outside of the European Union: a case-control study of epidemiological and clinical features. Epidemiol Infect 2001; 127:527-533.
22. Dray-Spira R, Spire B, Heard I, Lert F. Heterogeneous response to HAART across a diverse population of people living with HIV: results from the ANRS-EN12-VESPA Study. AIDS 2007; 21 (Suppl 1):S5-S12.
23. Mayaux MJ, Teglas JP, Blanche S. Characteristics of HIV-infected women who do not receive preventive antiretroviral therapy in the French Perinatal Cohort. J Acquir Immune Defic Syndr 2003; 34:338-343.
24. Staehelin C, Rickenbach M, Low N, Egger M, Ledergerber B, Hirschel B, et al. Migrants from Sub-Saharan Africa in the Swiss HIV Cohort Study: access to antiretroviral therapy, disease progression and survival. AIDS 2003; 17:2237-2244.
25. Mayaux MJ, Dussaix E, IsopetJ, Rekacewicz C, Mandelbrot L, Ciraru-Vigneron N, et al. Maternal virus load during pregnancy and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohort studies. SEROGEST Cohort Group. J Infect Dis 1997; 175:172-175.
26. Recommendations PHSTF. Use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal hiv-1 transmission in the United States. 2005. http://aidsinfo.nih.gov/
27. Sperling RS, Shapiro DE, Coombs RW, Todd JA, Herman SA, McSherry GD, et al. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1996; 335: 1621-1629.
28. Lallemant M, Jourdain G, Le Coeur S, Mary JY, Ngo-Giang-Huong N, Koetsawang S, et al. Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand. N Engl J Med 2004; 351:217-228.
29. Cao Y, Krogstad P, Korber BT, Koup RA, Mu ldoon M, Macken C, et al. Maternal HIV-1 viral load and vertical transmission of infection: the Ariel Project for the prevention of HIV transmission from mother to infant. Nat Med 1997; 3:549-552.
30. Dickover RE, Garratty EM, Herman SA, Sim MS, Plaeger S, Boyer PJ, et al. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load.. JAMA 1996; 275:599-605.
31. Garcia PM, Kalish LA, Pitt J, Minkoff H, QuinnTC, BurchettSK, et al. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. N Engl J Med 1999; 341:394-402.
32. The European Collaborative Study. Maternal viral load and vertical transmission of HIV-1: an important factor but not the only one. AIDS 1999; 13:1377-1385.
33. Mofenson LM, Lambert JS, Stiehm ER, Bethel J, Meyer WA, 3rd, Whitehouse J, et al. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team. N Engl J Med 1999; 341:385-393.
34. Meyer L, Chaix ML, Deveau C, Venet A, Pacanowski J, Nagy S, et al. Low CD4 T cell counts in sub-Saharan African patients with primary HIV-1 infection enrolled in the ANRS PRIMO Cohort. 4th IAS Conference. Sydney 2007.
35. NellenJ, Wit F, De Wolf F, Jurriaans S, Lange J, Prins J. Virologic and immunologic response to highly active antiretroviral therapy in indigenous and nonindigenous HIV-1-infected patients in the Netherlands. J Acquir Immune Defic Syndr 2004; 36:943-950.
36. Jensen-Fangel S, Pedersen L, Pedersen C, Larsen C, Tauris P, Moller A, et al. The effect of race/ethnicity on the outcome of highly active antiretroviral therapy for human immunodeficiency virus type 1-infected patients. Clin Infect Dis 2002; 35:1541-1548.
37. Bunders M, Thorne C, Newell ML. Maternal and infant factors and lymphocyte, CD4 and CD8 cell counts in uninfected children of HIV-1-infected mothers. AIDS 2005; 19:1071-1079.
38. Frater A, Dunn D, Beardall A, Ariyoshi K, Clarke J, McClure M, Weber J. Comparative response of African HIV-1-infected individuals to highly active antiretroviral therapy. AIDS 2002; 16:1139-1146.
39. Kassu A, Tsegaye A, Petros B, Wolday D, Hailu E, Tilahun T, et al. Distribution of lymphocyte subsets in healthy human immunodeficiency virus-negative adult Ethiopians from two geographic locales. Clin Diagn Lab Immunol 2001; 8:1171-1176.
40. Smith C, Sabin C, Youle M, Kinloch-de Loes S, Lampe F, Madge S, et al. Factors influencing increases in CD4 cell counts of HIV-positive persons receiving long-term highly active antiretroviral therapy. J Infect Dis 2004; 190:1860-1868.